ApprovalTrail

Approval · Notice of Compliance 31274 · 2023

OLIMEL 3.3% E: Notice of Compliance 31274

Issued July 19, 2023

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
31274
Date
July 19, 2023
Company
Baxter CorporationMississauga, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
To update the Product Monograph (PM) with new safety information.

Products in this notice

BrandDINStatus today
OLIMEL 3.3% ENot yet assigned—
OLIMEL 4.4% ENot yet assigned—
OLIMEL 5.7% ENot yet assigned—
OLIMEL 7.6% ENot yet assigned—
PERIOLIMEL 2.5% ENot yet assigned—

Medicinal ingredients